Related Experiment Video
Updated: Jan 14, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Mapping the Colorectal Cancer Patient Journey From the Oncologist Perspective in Saudi Arabia
Ahmed Alshehri1, Ahmed Omar Allehebi2,3, Fahad Almugbel4
1College of Medicine, King Saud Bin Abdulaziz University (KSAU) for Health Sciences, Jeddah, Saudi Arabia.
Purpose:
Mapping the colorectal cancer (CRC) patient pathway is needed to identify knowledge gaps and improve patient care. We aimed to understand the medical journey of patients and the role of the multidisciplinary team (MDT) in managing CRC in Saudi Arabia.
Methods:
A nationwide survey was administered to healthcare professionals (HCPs) in Saudi Arabia during August 1-September 15, 2024, to characterize typical patient profiles and CRC management.
Results:
Out of 33 responses, 28 were eligible, mostly were medical oncologists (96.4%) in tertiary healthcare settings (>85%) with 5-20 years of experience (78.6%). Most HCPs reported that patients had no or limited awareness of CRC (89.3%) and lacked access to support groups (71.4%). The guideline-recommended screening of individuals aged 45-75 years with no symptoms or a family history of CRC or polyps was only reported by 67.9% of respondents. Common screening methods were colonoscopy (89.3%) and fecal immunochemical test (53.6%). Major barriers to optimal CRC screening were patients' lack of awareness (92.9%) and challenges in accessing screening programs (75.0%). Gastroenterologists were the primary referrers to specialized centers and were responsible for diagnosing CRC (reported by 92.9% and 85.7%, respectively); 53.6% and 17.9% of respondents reported that surgical oncologists and an MDT also made the definitive diagnosis, respectively. Respondents identified the key MDT members taking care of patients with CRC as surgical (100.0%), medical (100.0%), radiation oncologists (92.9%), and pathologists (92.9%). Some MDTs involved other professionals, including radiologists (85.7%), clinical gastroenterologists (64.3%), dieticians (64.3%) and pharmacists (60.7%). The most common barrier to effective CRC treatment was delays in patient presentation (67.9%).
Conclusion:
The results give clinicians and public bodies the opportunity to address critical factors for improving the outcomes for CRC patients in Saudi Arabia.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

